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Background: Identification of parasite genes that underlie traits such as drug resistance and host specificity is
challenging using classical linkage mapping approaches. Extreme QTL (X-QTL) methods, originally developed by
rodent malaria and yeast researchers, promise to increase the power and simplify logistics of linkage mapping in
experimental crosses of schistosomes (or other helminth parasites), because many 1000s of progeny can be
analysed, phenotyping is not required, and progeny pools rather than individuals are genotyped. We explored the
utility of this method for mapping a drug resistance gene in the human parasitic fluke Schistosoma mansoni.
Results: We staged a genetic cross between oxamniquine sensitive and resistant parasites, then between two F1
progeny, to generate multiple F2 progeny. One group of F2s infecting hamsters was treated with oxamniquine,
while a second group was left untreated. We used exome capture to reduce the size of the genome (from 363 Mb
to 15 Mb) and exomes from pooled F2 progeny (treated males, untreated males, treated females, untreated
females) and the two parent parasites were sequenced to high read depth (mean = 95-366×) and allele frequencies
at 14,489 variants compared. We observed dramatic enrichment of alleles from the resistant parent in a small
region of chromosome 6 in drug-treated male and female pools (combined analysis: Z = 11.07, p = 8.74 × 10-29).
This region contains Smp_089320 a gene encoding a sulfotransferase recently implicated in oxamniquine resistance
using classical linkage mapping methods.
Conclusions: These results (a) demonstrate the utility of exome capture for generating reduced representation
libraries in Schistosoma mansoni, and (b) provide proof-of-principle that X-QTL methods can be successfully applied
to an important human helminth. The combination of these methods will simplify linkage analysis of biomedically
or biologically important traits in this parasite.
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Classical methods for QTL identification involve examin-
ation of cosegregation of markers and trait loci in the par-
ents and progeny of experimental genetic crosses or in
extended pedigrees [1,2]. However, this requires both phe-
notyping and genotyping of multiple individual progeny
which is time consuming, labor intensive, expensive and
places upper limits on statistical power [2]. Extreme QTL
(X-QTL) methods provide a simple way to circumvent
these disadvantages and are applicable to any selectable
trait (Figure 1). In X-QTL, large groups of progeny are* Correspondence: tanderso@txbiomedgenetics.org
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unless otherwise stated.selected for the trait of interest and compared with control
groups that are not exposed to selection. Selected and un-
selected pools are quantitatively genotyped to estimate fre-
quencies of genetic markers across the genome. Selected
and unselected pools show equal representation of fre-
quency across the genome, except in genome regions con-
taining the critical genes that underlie the selected trait.
X-QTL methods are a development of bulk segregation
methods, originally established by human and plant genet-
icists in the mid-1980s and the early 1990s [3-5], in which
individual progeny with different phenotypes were pooled
and genotyped. X-QTL methods were independently de-
veloped by researchers working on rodent malaria, where
the method was referred to as linkage group selection
[6-8] and was later used on yeast [9], where the termal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Principle of the extreme-QTL (X-QTL) analysis. X-QTL
analysis can be performed on a simple Mendelian inherited trait (for
instance drug susceptibility (dominant trait) and drug resistance
(recessive trait)) using pools of individuals (grey circle). Individuals
with susceptible phenotype (yellow balls) and resistant phenotype
(dark blue balls) are crossed to generate F1 and F2 individuals.
The F2 individuals are divided in two pools: one under no selection
(without drug treatment, light blue circle) and another under selection
(with drug treatment, red circle). The allele frequency is equal in
unselected (light blue line) and selected (red line) pools across
the genome, except in the genome region (chromosome 6 here)
containing the critical genes that underlie the selected trait.
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have adopted this term throughout.
Here we validate the X-QTL approach for linkage ana-
lysis of a biomedically important trait (oxamniquine
(OXA) resistance) in the human blood fluke Schistosoma
mansoni for which the causative gene (Smp_089320 on
chromosome 6) is now known [10]. Schistosomiasis, the
second most important tropical parasitic disease after mal-
aria [11], affects an estimated 187 million people across
Africa, Asia, and South America, killing over 200,000
people per year and is caused by blood flukes of the genus
Schistosoma [12-14]. Among the three major schistosome
species of medical importance, S. mansoni infects over 67
million people in Africa, Middle East and South America[15]. The life cycle of this parasite includes a snail as inter-
mediate host (Biomphalaria spp.) and humans as defini-
tive host. However, the complete lifecycle can be easily
maintained in the laboratory using snail and rodent hosts
(Additional file 1: Figure S1) [16], and there is a rich litera-
ture describing heritable variation in a range of biomedi-
cally and biologically interesting traits such as drug
resistance [17,18], host specificity [19], and virulence [20].
The 364.5 Mb genome of S. mansoni has been sequenced
[21], and with the aid of a 5 cM genetic map [22] 80% of
the scaffolds have been assigned and ordered on chromo-
somes [23]. The genome is composed of 7 autosomes and
one pair of ZW sex chromosomes and contains 10,852
genes. Forty percent of the genome is composed of repeti-
tive elements [21,23].
We have recently exploited the genome sequence and
genetic map to identify, by classical linkage mapping, a
QTL region underlying parasite resistance to oxamni-
quine, one of the two drugs used in the treatment of S.
mansoni infection [10]. This is the first trait mapped in
S. mansoni or in any human helminth infection and re-
sulted in direct identification of the gene and mutations
responsible for this trait. While classical genetic map-
ping is clearly feasible in this organism, it is extremely
labor intensive. In the oxamniquine genetic cross, 2,856
individual snails were exposed to single larval stages to
obtain 388 snails infected with F2 progeny, while measure-
ment of resistance involved daily observation of worm
death following drug exposure over a two week period for
each of the F2 progeny genotypes. Hence mapping of
OXA-resistance QTL required a concerted effort by three
researchers over a two year period. We therefore sought
to develop more efficient methods for linkage mapping in
this parasite.
X-QTL methods require accurate measurement of
genome wide allele frequencies within progeny pools.
This has been done by pyrosequencing [24], microarray
hybridization [25], and more recently by examining read
depth of SNPs using next generation sequence data
(Pool-seq) [26]. The genome of S. mansoni is relatively
large (364.5 Mb), and comprises ~40% repetitive se-
quences, so we sought to use reduced representation se-
quencing to minimize cost and maximize read depth in
F2 progeny pools. Several methods using restriction
enzymes have been developed for performing reduced
representation sequencing for complex genomes (e.g.
restriction-site-associated DNA sequencing (RAD-seq),
reduced-representation libraries (RRL)) [27]. We opted
to use exome capture rather than restriction based
methods for several reasons: (i) obtaining exome se-
quence data simplifies fine mapping of loci identified
following initial QTL location, as most variants involved
in phenotypic traits result from changes within coding
sequences [28], (ii) we wanted to avoid sequencing
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in a single genomic location (this is a particular concern
for S. mansoni given the repeat content of this genome),
(iii) polymorphisms within restriction sites have the po-
tential to bias representation of parental alleles within
progeny pools when using approaches such as RAD-seq
[29]. This can potentially generate spurious enrichment
of particular alleles within progeny pools. A second aim
of this work was therefore to evaluate the efficiency of
exome capture methods for S. mansoni.
Results
Genetic crosses
We staged a cross between an OXA-resistant (HR) male
and an OXA-sensitive (LE) female parasites by infecting
hamsters with 500 male and 500 female cercariae larvae
of a single genotype. These were derived from snails in-
fected with a single miracidium larva, which reproduce
clonally giving rise to 1000s of single sex, single geno-
type cercariae larvae. Male and female F1 parasites were
crossed in the same way and single F2 miracidia were
used to infect snails. 130 infected snails, each shedding
cercariae of a single recombinant genotype, were used in
the pooling experiments. These single genotype cercariae
comprised 39 male and 91 female genotypes.
Pooling of F2 progeny and selection of adult worm pools
Each of the F2 pools used to infect hamsters contained
754 cercariae, representing the 130 recombinant genotypes
(39 male and 91 female) (Additional file 2: Figure S2). We
balanced the sex ratio by adding 10 representatives of each
male genotype and 4 representatives of each female geno-
type to the pools used for each infection (390 (39 × 10)
male cercariae : 364 (91 × 4) female cercariae per pool).
Importantly, the F2 pools used to infect each of the six
hamsters were identical in their genetic composition, so
the impact of OXA-treatment on genome-wide allele fre-
quencies can be directly examined.
Forty F2 females and 16 F2 male adult worms (56 total)
survived oxamniquine treatment in the OXA-treatment
group (four hamsters). Higher female survival rate follow-
ing OXA treatment has been observed previously [30].
This represents a global survival rate of 1.86%, relative to
the total number of cercariae used in the infections [56/
(4 × 754) × 100 = 1.86%]. In the untreated group (two
hamsters), 131 females and 147 males (278 total) were re-
covered, representing 18.44% of the infecting dose [278/
(2 × 754) × 100 = 18.44%]. Hence OXA-treatment results
in a ~10-fold reduction in survival relative to controls,
consistent with strong drug selection.
Exome capture performance: quality and efficiency
A set of 125,046 120 bp baits was used to capture the S.
mansoni exome (Additional file 3: File S1) in the parentsand the pools of treated and untreated male and female
worms. The baits included 124,983 in the nuclear genome
and 63 in the mitochondrial genome. They covered 87.52%
of the S. mansoni exons (59,801 of 68,326 exons) and
accounted for 92.18% of the exome length (14,138,142 of
15,336,803 bp) but also included regions surrounding
exons (total length: 14,748,899 bp). No baits were designed
for capture exons in gene families that could not be unam-
biguously mapped to a single location in the reference gen-
ome. The sequences covered by baits are referred to as the
bait regions. Each captured exon was covered by 2 baits.
The bait regions had an average read depth of 95 - 366
reads in the 6 libraries. The distribution of the read depth
was similar between sexes except for parts of the Z chromo-
some in the females in which read depth is reduced by half
(Table 1, Figure 2). These genome regions (position 3.5-
19.5 Mb and 23.5-31 Mb) correspond to the heterochroma-
tin domain of the W chromosome (female sex-specific
chromosome) [31] and contain all the Z-specific markers of
the genetic map of S. mansoni (data not shown) [22].
The statistics for each library indicate efficient exome
capture (Table 2). We captured > 99% of the genome
covered by the baits in the aligned sequencing data
(Table 2). Furthermore, this high capture efficiency was
consistent across all six libraries, as well as on each
chromosome and on the unassembled scaffold sets.
The mean sequence read depth declines with distance
from the bait regions (Figure 3). Mean read depth was
reduced by ~70% at 100 bp, by ~50% at 250 bp, while at
2,500 bp read depth declined to 20-40% of the initial
read depth in the 6 libraries. Therefore exome capture
provides high read depth sequence for at least 250 bp
surrounding bait regions. Inclusion of the 2,500 bp sur-
rounding the bait regions accounted for 60 to 75% of the
sequenced data. Taking in account 50,000 bp around the
bait regions explained ~97% of the sequenced data.
Hence, in addition to the exons, we also captured adja-
cent genome regions containing promoters, transcrip-
tion binding sites and other features of interest.
Variant identification
We identified 14,489 variants in the bait regions of the
nuclear genome that were segregating between parents and
the F2 progeny. This represents one variant every 1.018 kb
on average. 4.10% (600 variants) and 19.91% (2,885 variants)
were heterozygous (allele frequency between 0.4 and 0.6) in
male parent (HR) and in female parent (LE), respectively,
suggesting elevated inbreeding in the male (HR) parent.
Among the 14,489 variants, 14,132 were SNPs, 187 were
insertions (1-22 bp), and 170 were deletions (1-16 bp).
X-QTL mapping: oxamniquine resistance QTL identification
We examined the differences in allele frequencies of
each variant between treated and untreated worm pools
Figure 2 Read depth of the bait regions for each sequenced library. Each plot shows read depth of bait regions on the assembled
chromosomes (red), on unplaced scaffolds that have been assigned to chromosomes or unassigned scaffolds (black). The black bars show the
position of Z-linked regions of the genome, which show approximately 50% reduction in read depth in female (ZW) compared with male
(ZZ) worms.













Total data Number of mapped reads 87,100,659 25,711,555 21,640,228 31,561,784 39,224,999 29,417,710
Bait regions1
Number of reads mapping to
bait regions
67,492,249 11,208,843 7,037,441 15,412,158 20,936,397 15,770,592
Percentage of reads mapping
to bait regions
77.49% 43.59% 32.52% 48.83% 53.37% 53.61%
Read depth
Mean 366 106 95 165 178 125
Median 274 65 82 133 159 104
Exome
Number of reads mapping to
exome
65,114,964 10,837,365 6,808,470 14,939,809 20,271,770 15,311,788
Percentage of reads mapping
to exome
74.76% 42.15% 31.46% 47.33% 51.68% 52.05%
Read depth
Mean 337 100 90 123 166 117




and non Z-linked regions2
Ratio of mean
read depth
0.54 1.00 0.54 0.55 1.01 0.97
1Bait regions extend beyond the exon boundaries, so the statistics for bait regions and exome are slightly different.
2The Z-linked regions are positioned between 3.5-19.5 Mb and 23.5-31 Mb on the Z chromosome.
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1 29280 29277 29275 29272 29275 29276 29276 99.98
2 13728 13714 13697 13713 13718 13719 13716 99.89
3 13263 13252 13246 13253 13258 13258 13259 99.93
4 11913 11912 11898 11910 11910 11910 11910 99.96
5 3112 3111 3108 3111 3111 3111 3111 99.95
6 6078 6073 6075 6076 6076 6078 6078 99.97
7 2845 2844 2842 2844 2844 2844 2843 99.95
W 23069 23069 23066 23065 23069 23068 23068 99.99
Unassembled
scaffolds
21695 21461 21451 21488 21490 21492 21493 99.01
Mitochondrial 63 63 63 63 63 63 63 100
Total (%) 100 99.78 99.74 99.80 99.81 99.82 99.82
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OXA-resistance (Figure 4). To do this we plotted the
p-values of the Z-scores from the allele frequency com-
parison for both male and female worms at each variant
across the bait regions. In addition, we examined the sig-
nificance of the combined Z -scores from the compari-
sons of each sex.
Comparison of treated and untreated female pools shows
72 significant positions, while for treated and untreated
male pools 118 positions were significant. Both compari-
sons reveal strongly significant enrichment of alleles from
the resistant parent at the end of chromosome 6. In the
female comparison, there were 40 significant positions
between positions 227,149 and 4,189,610 (|Z | ≥ 4.70, p ≤
1.27.10-6). Similarly, in the male comparison, there were 81
significant positions (|Z| ≥ 4.74, p ≤ 1.06.10-6) between po-
























Figure 3 Mean read depth of the bait regions plus their surrounding
baits decreases with the distance from the edge of the bait regions.observed in both male and female comparisons was pos-
ition 1,286,622 (Z = 8.69, p = 1.86.10-18 in females; Z =
6.97, p = 1.60.10-12 in males). This peak is 233.343 kb away
from the end of the causative gene (Smp_89320, position
1,519,965-1,524,755) involved in oxamniquine resistance,
which was recently identified by conventional linkage
methods [10]. We also observed a second major region
(unassembled scaffold SC_0154) that shows enrichment of
alleles in both male and female comparisons. This scaffold
accounts for 22 significant polymorphisms (|Z| ≥ 4.74, p ≤
1.06.10-6) in females and 13 (|Z | ≥ 4.72, p ≤ 1.18.10-6) in
males.
The remaining significant genome positions (10 in fe-
males and 24 in males) were not consistent between the
two comparisons. For example, a region on chromosome
Z at positions 12,660,165, 15,218,811, 16,201,782, and
23,950,413 (| Z | ≥ 4.74, p ≤ 1.04.10-6) accounted for 4p)
2500
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Figure 4 X-QTL mapping of the oxamniquine resistance QTL. p-values showing the significance of difference in allele frequencies between
the treated and untreated pools. In red the region belonging to the assembled chromosomes, in black the region belonging to unplaced
scaffolds on the chromosomes or the unassembled scaffolds. The arrow head shows the position of the known SNP of the gene involved in
oxamniquine resistance [10]. The dash blue line corresponds to the Bonferroni correction.
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6 significant positions were found on chromosomes 1 and 2,
and within unassigned scaffolds. In males only, a region of
chromosome 2 (positions 17,450,959-29,107,158, | Z | ≥
4.74, p ≤ 1.07.10-6) shows marginally significant values at
11 variants. The other remaining 13 significant positions
were found on chromosomes 1, 3, 4, Z, and within un-
assigned scaffolds.
Plotting the combined Z-scores from the female and
male strengthens the signal revealed in both male and fe-
male comparisons. Of 166 significant positions genome-
wide, chromosome 6 (between positions 55,761 and
10,770,876), accounts for 79 significant positions (|Z | ≥
4.74, p ≤ 1.08.10-6), including the most significant (position
1,286,622, Z = 11.07, p = 8.74.10-29). The unassembled
scaffold SC_0154 previously identified in both female andmale mapping was confirmed in this combined mapping,
with 37 significant positions (|Z | ≥ 4.72, p ≤ 1.20.10-6).
The other remaining 50 significant positions were found
on chromosomes 1, 2, 3, 4, Z, and within unassigned
scaffolds.
Discussion
Efficiency of exome capture
Capture was extremely efficient since more than 99% of
the targeted regions were recovered and sequenced to
high read depth in the six libraries (95-366×) on two
lanes of an Illumina HiSeq. Furthermore, while the ex-
ome constitutes just 4% of the genome, between 32% to
77% of the capture sequences mapped to the bait re-
gions. The exome bait sequences also captured adjacent
non-coding DNA, with sequence read depth dropping to
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bait regions, as commonly found in exome capture ex-
periments with other organisms [32]. This is an added
bonus for functional genomics applications as promoter
polymorphisms and other regulatory sequences are often
located within 250 bp of coding regions [33]. We also
obtained low read depth of sequence from genome re-
gions up to 50 kb distant from bait regions.
Genotyping of modest numbers of microsatellite
loci (7-12) is widely used for population genetics of
schistosomes [34,35]. In this study we genotyped 14,489
exonic SNPs (one every 1.018 kb on average) segre-
gating in a single genetic cross. Dense genotyping by
exome sequencing will provide a powerful approach
for population genomic analysis of schistosome popula-
tions. A complication of working with schistosome in-
fections of humans is that adults are found in the blood
vessels and only eggs can be collected from infected pa-
tients. However, exome sequencing of miracidia hatched
from eggs should be possible following whole genome
amplification [36].
Analysis of the relative read depth suggests that exome
sequencing will be useful for analysis of copy number
variation. Males carry two Z chromosomes while females
carry only one Z chromosome and a W chromosome
[37]. Z and W chromosomes share extensive regions of
homology (pseudo-autosomal regions), but there are also
Z-linked regions that are present as a single copy in fe-
males and two copies in males. The presence of Z-linked
regions can be clearly inferred from the read depth plot
in the sex chromosomes of males and females (Figure 2).
These regions correspond exactly to those identified by
Lepesant et al. and carrying W specific sequences [31],
and also correspond to the positions of markers showing
Z-linked inheritance patterns in the cross used to con-



















Figure 5 Comparison of the p-values from the X-QTL mapping and th
The LOD scores are those obtained by the classical linkage mapping previo
and are superposed to the p-values from the combined Z scores used forValidation of X-QTL for Schistosoma mansoni
The X-QTL analysis successfully identified a region of
chromosome 6 showing enrichment of alleles from the
drug resistant parent in both male and female compari-
sons. This region contains the causative locus underlying
resistance to this recessive trait (Smp_089320) that was
identified using classical linkage mapping [10]. The gen-
ome position showing the lowest p-value was 233 kb
(<1 cM) from Smp_089320. This precision is extremely
encouraging, given the small number of progeny in the
pools. Moreover, when comparing the LOD scores ob-
tained using the classical linkage mapping and the p-values
obtained from the combined Z scores used for X-QTL,
the results are extremely similar (Figure 5).
The X-QTL analysis also revealed another region linked
to oxamniquine resistance. Both female and male compar-
isons identified multiple positions (22 in females and 13 in
males) on an unassigned scaffold (SC_0154) showing sig-
nificant peaks. We suggest two possible explanations.
First, this scaffold could belong to the end of the chromo-
some 6, adjacent to the major QTL peak identified. Sec-
ond, this scaffold could be positioned elsewhere in the
genome and identify a second QTL region influencing re-
sistance. We believe that the second explanation is very
unlikely because the oxamniquine resistance trait shows a
simple recessive inheritance [17] and only a single QTL
was identified by classical linkage mapping [10].
The ability of this X-QTL study to correctly map the
genome region underlying oxamniquine resistance is
particularly remarkable given that two features of our
experimental design were suboptimal. First, QTL is most
powerful when large numbers of segregating progeny are
examined [2]. However, in this experiment just 16 male
worms survived drug treatment and were included in the
treated male pool, while 40 treated females comprised the
















e LOD scores from the classical mapping by Valentim et al. [10].
usly used to identify the QTL involved in the oxamniquine resistance
the present X-QTL mapping.
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within the known QTL region on chromosome 6. Second,
we used whole genome amplification to generate sufficient
amounts of initial DNA for exome capture and library
preparation, rather than directly using genomic DNA.
While whole genome amplification has been demonstrated
to show high fidelity in S. mansoni [36], we expected that
this procedure would add further experimental noise by
reducing the precision of allele frequency estimation. In
view of the efficiency of X-QTL to identify QTL regions
for a simple Mendelian trait under suboptimal conditions
(i.e. using very small numbers of pooled progeny and
whole genome amplification), we expect that this ap-
proach will be extremely powerful for investigating the
basis of more complex traits, when experimental design
is optimal (i.e. large numbers of F2 in progeny pools
and no whole genome amplification).
We suggest that the small number of weakly significant
peaks observed in regions outside the chromosome 6
QTL or scaffold SC_0154 are unlikely to impact OXA re-
sistance. Instead we believe these peaks result from the
small size of the population samples from OXA-treated
pools. We note that the pooled F2 progeny were con-
structed using 10 male and 4 female cercariae of each
genotype. Hence, while 16 male and 40 female adult worms
were recovered from treated hamsters, the actual number
of independent genotypes may have been lower than this
(as few as 2 male genotypes and 10 female genotypes).
Hence, our statistical correction of sampling effects may be
insufficiently stringent. We suggest that future applications
of X-QTL to schistosomes should focus on increasing
the size of pools analyzed to minimize the impact of such
sampling effects.
Besides simplifying QTL identification for simple or
complex traits, X-QTL may be the only suitable method
for mapping some traits, such as host specificity or com-
patibility. Schistosomes vary in ability to infect popula-
tions of host snails, and this variation has been shown to
be heritable [19,38]. While crosses can be made between
parasites utilizing different snail hosts, classical QTL
mapping is problematic because F2 parasites that fail to
develop in a particular host snail cannot be genotyped.
This problem can be resolved by X-QTL analysis, be-
cause allele frequencies can be compared between emer-
ging parasite pools from the two host snail populations
to identify the genome region(s) associated with specific
development within each snail.
Conclusion
In summary, this study extends the use of X-QTL methods
to a multicellular parasite, the human blood fluke S. man-
soni, and demonstrates the utility of this approach for a
wide range of multicellular eukaryotes. The approach was
validated by remapping a QTL for oxamniquine resistance,which was recently located using classical linkage mapping
methods. This method opens the way for future QTL
mapping of traits of biomedical or biological significance
in schistosomes such as praziquantel resistance, host spe-
cificity, and virulence to both snail and vertebrate host.
The study also demonstrates that exome capture consti-
tutes a cost effective approach for genotyping in X-QTL
studies. For S. mansoni, this approach reduced genome
size by ~25-fold, thereby reducing sequencing costs, while
maximizing read depth and thereby allowing accurate
measurement of allele frequency within pooled samples.
Methods
Ethics statement
This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
The protocol was approved by the Institutional Animal
Care and Use Committee of the University of Texas
Health Science Center at San Antonio (Permit Numbers:
08093X and 11087X).
Schistosoma mansoni populations
The two laboratory maintained populations of S. man-
soni used in this study are the HR population (oxamni-
quine resistant) and the LE population (oxamniquine
sensitive). Oxamniquine resistance in HR was selected in
the laboratory. The HR population was isolated from a
Puerto Rican child by Dr. E. Bueding, then transferred to
Dr. Donato Cioli at the Laboratory of Cell Biology
in Rome and submitted to further drug selection at
Dr. Cioli’s laboratory [39]. The LE population was ori-
ginally isolated from a patient in 1965 in Belo Horizonte,
Brazil, and has since been maintained in the laboratory
[40]. Laboratory isolates of schistosomes are genetically
variable and are generally maintained as outcrossed pop-
ulations. We therefore used isogenic parasites generated
by infecting snails with single miracidia for conducting
genetic crosses (see below).
Genetic cross
We crossed an LE female to a HR male to generate F1
progeny. Subsequently, a male and female from the F1
were crossed to generate F2 progeny (reared to the adult
stage).
For each generation, parasites were obtained as fol-
lows: Eggs were collected from the liver and hatched
under light to obtain miracidia. Snails (B. glabrata) were
then infected with only one miracidium. Because sex is
determined in the zygote (which develops into a mira-
cidium) by a ZW chromosomal system, monomiracidial
infections allowed us to be certain that we were using
single clonal types (that is, single genetic individuals of
the same sex) in the crosses. After 28 days, snails were
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tosomes proliferate clonally, so the emerging cercariae
from a snail infected with a single miracidium form a gen-
etically homogeneous population of a single sex. Cercariae
were sexed following the protocol described in Criscione
et al. [22]. Briefly, DNA from cercariae shed by monomir-
acidial infected snails was extracted using Chelex® and
PCR was performed to discriminate between males and fe-
males using the W1 primers [41], which are specific to a
repetitive region on the W chromosome in females. As
this test depends on the failed amplification in males, we
performed a concurrent PCR under the same conditions
with the autosomal locus sc18 [22] to ensure that the
DNA had successfully been extracted from each sample.
Upon identification of gender, snails were shed again to
collect cercariae for infections. To establish parental and
F1 crosses, hamsters (one for each generation) were ex-
posed to 500 female cercariae of a single genotype and
500 male cercariae of a single genotype. For F2 progeny,
390 male cercariae representing 39 genotypes and 364
female cercariae representing 91 genotypes were used to
infect each of 6 hamsters (Additional file 2: Figure S2).
After 45 days, hamsters were euthanized and perfused to
collect adult worms and eggs from the liver for the next
generation [42].
The parent worms were separated by sex and pooled
for DNA extraction.
Phenotypic selection
We identified all snails that were infected with F2 schisto-
somes, and sexed the cercariae larvae emerging. We then
made replicate pools of F2 cercariae for infecting hamsters.
These pools (i) had identical composition of cercariae from
each infected snail (Additional file 2: Figure S2). Hence,
changes in allele frequency in control and treated animals
at markers should reflect the action of drug selection.
Following maturation, the F2 adult worms were first
selected for drug resistance in vivo. On day 43, 45, and
48 post-infection, the four F2 infected hamsters in the
treatment group were treated by gavage with 50 mg.kg-1
oxamniquine solubilized in 2.5% (m/v) Cremophor® EL
(Sigma-Aldrich). Two F2 infected hamsters were un-
treated, receiving only the diluent.
On day 50 of infection, hamsters were euthanized and
perfused to collect adult worms [42]. Adult worms were
transferred to a petri dish containing DMEM culture
media (Dulbecco-Modified Minimum Eagle’s Medium,
high glucose (4.5 g.L-1), bicarbonate buffered (3.7 g.L-1))
supplemented with 20% newborn calf serum, 100 U.mL-1
penicillin, 100 μg.mL-1 streptomycin, and 0.5 μg.mL-1
amphotericin B. Worms perfused from the four treated
hamsters were further treated in vitro with 500 μg.mL-1
oxamniquine solubilized in DMSO (Sigma-Aldrich) for
45 minutes, followed by 3 washes with drug-free mediumand incubated at 37°C in an atmosphere of 5% CO2 for 12
consecutive days. The in vitro treatment was done to en-
sure that all drug sensitive worms were dead. Adult worms
perfused from the two control hamsters were treated in
the same way, but exposed only to the diluent. The surviv-
ing worms from treated and untreated control group were
then separated by sex, counted and pooled for DNA
extraction.
Genomic DNA extraction and whole genome amplification
We prepared DNA from the two parental genotypes and
from four pools of F2 progeny (untreated males, oxam-
niquine treated males, untreated females, oxamniquine
treated females). Male and female worms were separated
for three reasons: (i) males are bigger than females and
contain more DNA, which biases allele frequency meas-
urement in mixed pools, (ii) males and females carry dif-
ferent sex chromosomes (ZZ for males, ZW for females),
so separation of males and females allows analysis of sex-
linked traits, and (iii) male and female worms serve as in-
ternal replication of the experiment. Adult worms from
each pool were placed in 200 μL of 6% Chelex® containing
0.2 mg.mL-1 of proteinase K, incubated at 56°C for 2 h,
and boiled at 100°C for 8 minutes. For each pool, four in-
dependent whole genome amplifications (WGA) were per-
formed using the GenomiPhi V2 DNA amplification kit
(GE Healthcare) [36] and then pooled to minimize bias
from the WGA. DNA was quantified using the Qubit®
dsDNA BR assay (Invitrogen).
Exome capture and sequencing
The S. mansoni exome was captured using the SureSe-
lectXT Target Enrichment System (Agilent) according to the
manufacturer’s protocol. Three micrograms of WGA DNA
were used for each library preparation. The PCR cycles
used for the pre-capture and post-capture amplifications
were 4 and 12, respectively. The capture was performed
using baits (120 bp RNA molecules) specifically designed
by Agilent based on the exon annotation of the S. mansoni





coded libraries from the exome capture were sequenced
using 100 bp pair-end method on two lanes of a HiSeq
2000 sequencer (Illumina). Raw sequence data has been
submitted to the NCBI Sequence Read Archive under ac-
cession number SRP033214.
Sequencing data processing, variant identification and
functional effect prediction
The sequencing data were aligned against the S. mansoni
reference genome (v. 5) using BWA (v. 0.6.1) [43] and
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score recalibration (using SNPs from [10]), and variant
(SNP/indel) calling by the UnifiedGenotyper module were
performed using GATK (v. 1.4-37) [45,46]. Bait represen-
tation, capture efficiency and read depth analyses were
performed using BEDTools (v. 2.14.3) [47].
The variant calling set was filtered using a minimum
Q-score of 40, and a minimum read depth of 10, re-
spectively, in the parental parasites. To refine the calling
set, a minimum read depth of 40 was applied for the var-
iants detected in the F2 related libraries. We retained
only F2 variants that were segregating in the treated
and/or untreated worm pools of each sex.
Statistical analysis and extreme-QTL mapping
We expect the genome region underlying resistance to
be enriched in sequence reads from drug treated F2s.
To evaluate statistical evidence for such enrichment, we
examined the difference in allele frequencies between
treated and untreated F2 pools across the exome. To
minimize the bias induced by the unequal number of
worms in each treatment and control groups and the
difference in the read depth from the different libraries,
Z-scores for each variant were weighted as follows:
Z ¼ p1−p2ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p0 1−p0ð Þ 1x:n1 þ 1x:n2 þ 1d1 þ 1d2
 r
where p1 and p2 are the estimated allele frequencies in the
treated and untreated pools, respectively; p 0 is the allele
frequency under the null hypothesis H0: p1 = p2 estimated
from the average of p1 and p2; n1 and n2 are the number
of worms in the treated and untreated pools, respectively,
factor x for each n reflecting the ploidy state (x=2 except
for the haploid Z-linked regions in females where x=1);
and d 1 and d 2 are the sequencing depths for the treated
and untreated pools, respectively.
Z-scores were computed at each variant site and for the
comparison between treated and untreated worm pools of
each sex. As worm pools from male and female worms
were analyzed separately, Z-scores were also combined for
each variant as follows:
Zc ¼ Zf þ Zmﬃﬃﬃ
2
p
where Zf and Zm were Z -scores from female and male
pools, respectively. The p-values were obtained by com-
paring the negative absolute value of Z -scores to the
standard normal distribution. To determine the signifi-
cant threshold, Bonferroni correction was calculated
with α = 0.05. These analyses and the graphical re-
presentation of the results were conducted using R
(v. 2.14.2) [48].Additional files
Additional file 1: Figure S1. Schistosoma mansoni life cycle. The life
cycle involves both an aquatic snail intermediate (Biomphalaria spp.) and
a human definitive host. Rodents can be used to maintain the life cycle
in the laboratory. (1) Male (large) and female (thin) adult worms are
found in the portal vein. When the worm pairs mate, they migrate into
the venules draining the intestine where the females lay eggs which
then pass through the intestine wall into the lumen. (2) Eggs leave the
body with the feces and hatch in fresh water. (3) Motile miracidia
penetrate the intermediate snail host, miracidia differentiate into
sporocysts, proliferating asexually. (4) Snails release motile clonal cercariae
into the water. (1) Cercariae penetrate the skin of a mammalian host, and
migrate through the bloodstream to the hepatic portal system where
they develop into adult worms. In the laboratory, the entire life cycle
takes 75 to 90 days to complete. Schistosoma mansoni is diploid with
separate sexes. This aids in the staging of genetic crosses because
clonally generated male and female larvae from monomiracidial infected
snails can be used to infect mice.
Additional file 2: Figure S2. F2 adult worm production, selection
procedure and pooling strategy. F2 adult worms are obtained by
infecting 6 hamsters using identical pools of 390 male cercariae
(representing 39 unique genotypes) and 364 female cercariae
(representing 91 genotypes). A first in vivo drug selection was performed
when worms reach maturity within each hamster by treating them with
oxamniquine (treated pool) or with diluent only (untreated pool). Worms
were then recovered by perfusion, separated by sex and treated again
in vitro. Surviving worms were finally pooled and DNA extracted. n:
number of worms constituting the pool.
Additional file 3: File S1. Coordinates of the baits used for exome
capture across the S. mansoni genome. Genomic coordinates of the
125,046 baits used to capture the S. mansoni exome. These baits were
designed using the version 5 of the genome and the version 4 of the
annotation (gff) file.
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